Page last updated: 2024-09-03

hexahydrodifenidol and Neuroblastoma

hexahydrodifenidol has been researched along with Neuroblastoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aasen, A; Camus, J; Christophe, J; Lambrecht, G; Mutschler, E; Schjelderup, L; Strohmann, C; Tacke, R; Tastenoy, M; Waelbroeck, M1
Camus, J; Christophe, J; Lambrecht, G; Mutschler, E; Strohmann, C; Tacke, R; Tastenoy, M; Waelbroeck, M1

Other Studies

2 other study(ies) available for hexahydrodifenidol and Neuroblastoma

ArticleYear
Stereoselective interaction of procyclidine, hexahydro-difenidol, hexbutinol and oxyphencyclimine, and of related antagonists, with four muscarinic receptors.
    European journal of pharmacology, 1992, Sep-01, Volume: 227, Issue:1

    Topics: Alkynes; Animals; Corpus Striatum; Heart; Humans; In Vitro Techniques; Male; N-Methylscopolamine; Neuroblastoma; Pancreas; Parasympatholytics; Piperidines; Procyclidine; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine Derivatives; Stereoisomerism; Tritium

1992
Stereoselectivity of (R)- and (S)-hexahydro-difenidol binding to neuroblastoma M1, cardiac M2, pancreatic M3, and striatum M4 muscarinic receptors.
    Chirality, 1991, Volume: 3, Issue:2

    Topics: Animals; Binding, Competitive; Corpus Striatum; Humans; Male; Myocardium; Neuroblastoma; Pancreas; Piperidines; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Stereoisomerism

1991